radium ra-223 dichloride
bayer
['reassure', 'crpc']
reassure study: rw safety &amp; effectiveness of ra-223 in pts w/ mcrpc in #asco23 n=498, mfu 11.9 mo 81% bone mets, 69% 5-6 inj ra-223 concomitant enza: 31% concomitant bha: 47% 58% pts w/ a baseline bpi-sf 2: meaningful pain response mos: 17.8 mos 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor